Society for Clinical Research Sites Receives Unprecedented Response from Industry Stakeholders to Support Sites by Joining Corporate Partnership Program

ROCKVILLE, Md., June 20, 2013 /PRNewswire/ -- The Society for Clinical Research Sites (SCRS) is proud to announce the launch of the Global Impact Partnership (GIP) Program.  In just over a month, twelve organizations have joined SCRS' commitment to research site's success.  SCRS Global Impact Partners will provide ongoing development, feedback, and support of industry initiatives designed to include and improve the voice of clinical research sites.  In just seven months since its announcement, SCRS has grown its global membership to represent 1,300 sites in 12 countries.  Within a constantly evolving industry, the Global Impact Partnership Board will work in tandem with SCRS' Leadership Council to identify the work streams most significant to the success of research sites across the world.  Each GIP member will appoint one executive level team member to represent their organization and each organization has made a two year commitment to SCRS. 

The founding GIP industry partners include:
Amgen, AstraZeneca, Eli Lilly, PPD, and Roche

While GIP professional partners include:
Acurian, Aspire IRB, Bio-Optronics, Inc., CFS Clinical, Clinical Site Services, DAC Patient Recruitment Services, and ePharmaSolutions.

More industry GIP members will be announced in the months ahead as are invited.  However, the supplier seats are limited to only 12 organizations.  The first meeting of the GIP Board will be held at this year's Site Solutions Summit in Amelia Island, FL.  The GIP Board will work towards industry changes from operational management, to contracts, to subject retention, and more.  Their collaboration will SCRS continue throughout the year.

SCRS President, Christine Pierre states that "The response we have received from sites joining at such a rapid rate was not a surprise; sites are committed to the industry and to our volunteers.  However, the response our community of sites has received from industry has affirmed that the mission of SCRS to represent the global site community and ensure our voice is heard was long overdue, and they want to be a part of the advancement of SCRS.  It has long been my position that success in the clinical research ecosystem is dependent on the foundation of a strong site base.  Without sites there are no subjects, without subjects there are no new treatments.  Critical success factors are different around the globe, and we look forward to working with our GIPs, Leadership Council and SCRS members to ensure all sites succeed."

About SCRS
SCRS is a trade organization representing global clinical research sites representing 1,300 sites in 12 countries in just seven months of its launch. SCRS' mission is to unify and amplify the voice of the global clinical research site community. SCRS has become an active partner in industry-wide dialogues focused on improving the clinical research enterprise among the many industry initiatives. Sites, as well as companies that sponsor or support the work conducted at the clinical research sites, will also benefit from membership. Visit www.myscrs.org.

SOURCE Society for Clinical Research Sites